Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...

Growing investments in healthcare infrastructure and advancements in medical research facilities are driving the expansion of ...

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Mitral valve disease is a condition that affects the mitral valve, causing blood to leak backward or flow too slowly, and can ...

Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...

The Duke team performed the world’s first living mitral valve replacement, a type of partial heart transplant, which Duke ...

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

ST. LOUIS — Dr. Scally, a cardiothoracic surgeon with Prairie Cardiovascular in O’Fallon, Illinois, explains mitral valve disease, a condition that affects the mitral valve, which controls ...

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and can lead to a domino effect of life-saving procedures.

In a groundbreaking series of surgeries, doctors at Duke Health have successfully performed the world’s first living mitral valve replacement.

Doctors told the family that Margaret’s mitral valve had holes in it and would fail. She needed a new valve. “I was very scared,” Margaret told TODAY. “Instead of having the one hole in my ...